Skip to main content
Premium Trial:

Request an Annual Quote

BGI Bloodstream Pathogen Nucleic Acid Detection Kit Gets CE Mark

NEW YORK – BGI said last week that its nucleic acid detection kit for bloodstream infection pathogens has received the CE mark.

The kit, developed by BGI Patho-Genesis Pharmaceutical Technology, a holding subsidiary of BGI Genomics, uses combinatorial probe-anchor synthesis technology to prepare libraries for metagenomic sequencing to detect pathogens that cause bloodstream infections. It is designed to construct a sequencing library directly from clinical samples.

The sequencing data is analyzed using dedicated software and compared to a curated microbial genome reference database for the detection of pathogens including bacteria, fungi, viruses, and parasites. 

According to Shenzhen, China-based BGI, the kit has already been used widely in clinical practice to identify pathogens causing bloodstream infection.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.